These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22450981)

  • 1. Preclinical monitoring of drug association in experimental chemotherapy of Chagas' disease by a new HPLC-UV method.
    Moreira da Silva R; Oliveira LT; Silva Barcellos NM; de Souza J; de Lana M
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3344-8. PubMed ID: 22450981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of Benznidazole in Experimental Chronic Chagas Disease Using the Swiss Mouse-Berenice-78 Trypanosoma cruzi Strain Model.
    de Jesus SM; Pinto L; Moreira FL; Nardotto GHB; Cristofoletti R; Perin L; Fonseca KDS; Barbêdo P; Bandeira LC; Vieira PMA; Carneiro CM
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Tissue Distribution of Benznidazole after Oral Administration in Mice.
    Perin L; Moreira da Silva R; Fonseca KD; Cardoso JM; Mathias FA; Reis LE; Molina I; Correa-Oliveira R; Vieira PM; Carneiro CM
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease.
    Araújo MS; Martins-Filho OA; Pereira ME; Brener Z
    J Antimicrob Chemother; 2000 Jun; 45(6):819-24. PubMed ID: 10837436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benznidazole, itraconazole and their combination in the treatment of acute experimental chagas disease in dogs.
    Cunha ELA; Torchelsen FKVDS; Cunha LM; de Oliveira MT; Fonseca KDS; Vieira PMA; Carneiro CM; de Lana M
    Exp Parasitol; 2019 Sep; 204():107711. PubMed ID: 31254494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of Benznidazole in Healthy Volunteers and Implications in Future Clinical Trials.
    Molina I; Salvador F; Sánchez-Montalvá A; Artaza MA; Moreno R; Perin L; Esquisabel A; Pinto L; Pedraz JL
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults.
    Altcheh J; Moscatelli G; Mastrantonio G; Moroni S; Giglio N; Marson ME; Ballering G; Bisio M; Koren G; García-Bournissen F
    PLoS Negl Trop Dis; 2014 May; 8(5):e2907. PubMed ID: 24853169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics and biodistribution of benznidazole in mice.
    Perin L; Pinto L; Balthazar Nardotto GH; da Silva Fonseca K; Oliveira Paiva B; Fernanda Rodrigues Bastos Mendes T; Molina I; Correa-Oliveira R; Melo de Abreu Vieira P; Martins Carneiro C
    J Antimicrob Chemother; 2020 Aug; 75(8):2213-2221. PubMed ID: 32356873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease.
    Corrales M; Cardozo R; Segura MA; Urbina JA; Basombrío MA
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1556-60. PubMed ID: 15793138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on benznidazole for the treatment of patients with Chagas disease.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with benznidazole in association with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi: investigation into the possible development of neoplasias.
    Andrade SG; Mesquita IM; Jambeiro JF; Santos IF; Portella RS
    Rev Soc Bras Med Trop; 2003; 36(4):441-7. PubMed ID: 12937719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease.
    Sosa Estani S; Segura EL; Ruiz AM; Velazquez E; Porcel BM; Yampotis C
    Am J Trop Med Hyg; 1998 Oct; 59(4):526-9. PubMed ID: 9790423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dog as model for chemotherapy of the Chagas' disease.
    Guedes PM; Veloso VM; Tafuri WL; Galvão LM; Carneiro CM; Lana Md; Chiari E; Ataide Soares K; Bahia MT
    Acta Trop; 2002 Oct; 84(1):9-17. PubMed ID: 12387906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effect of benznidazole against parasite reactivation in patients chronically infected with Trypanosoma cruzi and treated with corticoids for associated diseases].
    Rassi A; Amato Neto V; de Siqueira AF; Ferriolli Filho F; Amato VS; Rassi Júnior A
    Rev Soc Bras Med Trop; 1999; 32(5):475-82. PubMed ID: 10881079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during therapy with benznidazole in children with indeterminate form of Chagas' disease.
    Laucella SA; Segura EL; Riarte A; Sosa ES
    Clin Exp Immunol; 1999 Dec; 118(3):423-7. PubMed ID: 10594562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease.
    Guerrero L; Pinazo MJ; Posada E; Gascón J; Ribas J; Soy D
    Clin Chem Lab Med; 2011 Jan; 49(1):77-82. PubMed ID: 21083440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes.
    Toledo MJ; Bahia MT; Carneiro CM; Martins-Filho OA; Tibayrenc M; Barnabé C; Tafuri WL; de Lana M
    Antimicrob Agents Chemother; 2003 Jan; 47(1):223-30. PubMed ID: 12499195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.
    Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S;
    J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.
    de Andrade AL; Zicker F; de Oliveira RM; Almeida Silva S; Luquetti A; Travassos LR; Almeida IC; de Andrade SS; de Andrade JG; Martelli CM
    Lancet; 1996 Nov; 348(9039):1407-13. PubMed ID: 8937280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.